Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

Extending anti-clotting treatment linked to lower rates of new clots

Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published ...

High blood pressure in children nearly doubled from 2000–2020, global study finds

The rate of children and adolescents experiencing high blood pressure worldwide nearly doubled between 2000 and 2020, according to a new meta-analysis published in The Lancet Child & Adolescent Health journal.

Q&A: How to have a heart-healthy Thanksgiving

Thanksgiving is a time to gather with loved ones, give thanks, and savor the flavors of the season. But for anyone striving to eat heart-healthy, the holiday can present some challenges. With buttery sides, decadent desserts, ...

New pediatric basic life support guidelines seek to improve outcomes, optimize care, says co-author

While sudden cardiac arrest in a child or adolescent is rare—about 20,000 cases occur each year in the U.S.—the survival rate when it happens outside of a hospital is estimated to be under 20%. Significantly improving ...

'Humanized' model developed to study heart valve stiffness

The first ever "humanized" model for aortic valve calcification paves the way for testing potential treatments.

Very low LDL-cholesterol correlates to fewer heart problems after stroke

Brigham and Women's Hospital's TIMI Study Group reports that in patients with prior ischemic stroke, very low achieved LDL-cholesterol correlated with fewer major adverse cardiovascular events and fewer recurrent strokes, ...

Todays Updates

Making informed decisions and managing regret after prostate cancer treatment

A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, you may be faced with multiple treatment options and asked to make a choice—surgery, radiation ...

Food insecurity linked to tumor growth in pediatric neuroblastoma

Neuroblastoma remains one of the deadliest childhood malignancies, accounting for a disproportionate number of pediatric cancer deaths worldwide.

Todays Updates

Making informed decisions and managing regret after prostate cancer treatment

A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, you may be faced with multiple treatment options and asked to make a choice—surgery, radiation ...

Food insecurity linked to tumor growth in pediatric neuroblastoma

Neuroblastoma remains one of the deadliest childhood malignancies, accounting for a disproportionate number of pediatric cancer deaths worldwide.

Latest News

Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published ...

The rate of children and adolescents experiencing high blood pressure worldwide nearly doubled between 2000 and 2020, according to a new meta-analysis published in The Lancet Child & Adolescent Health journal.

Thanksgiving is a time to gather with loved ones, give thanks, and savor the flavors of the season. But for anyone striving to eat heart-healthy, the holiday can present some challenges. With buttery sides, decadent desserts, ...

While sudden cardiac arrest in a child or adolescent is rare—about 20,000 cases occur each year in the U.S.—the survival rate when it happens outside of a hospital is estimated to be under 20%. Significantly improving ...

The first ever "humanized" model for aortic valve calcification paves the way for testing potential treatments.

Brigham and Women's Hospital's TIMI Study Group reports that in patients with prior ischemic stroke, very low achieved LDL-cholesterol correlated with fewer major adverse cardiovascular events and fewer recurrent strokes, ...

News All Time

Family history of heart disease linked to specific protein pattern in blood

A specific pattern of proteins in the blood may reflect an increased risk of hereditary atherosclerosis. This is shown in a new study from Karolinska Institutet, examining close relatives of people who had suffered a heart ...

Patients with peripheral arterial disease and Afib found to face higher risk for cardiac events

New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face a significantly higher risk of major adverse cardiovascular ...

High blood pressure in your 30s tied to heart attack risk

People in their 30s may risk a heart attack or stroke in later life even when they have "normal" blood pressure, if it's too high or steeply rising, according to a new study led by UCL researchers.

Stress MRI may boost angina diagnosis, treatment

Chest pain may still be angina even when coronary angiogram testing shows the main heart arteries look clear. Using stress cardiac stress MRI testing to measure blood flow around the heart appears to improve diagnosis and ...

PCSK9, statin combo may cut cholesterol post-transplant

The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by more than 50% among patients after a heart transplant, according to a late-breaking science presentation ...

Combo pill boosts heart function, symptoms, life quality

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, better quality of life, ...

Beta-blockers are no longer needed in post-infarction patients with normal heart function, study confirms

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors with preserved cardiac ...

Cancer-causing contaminant in blood pressure pills may point to higher safety risks in older generic drugs

A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines.

Stenting all blocked arteries outperforms culprit-only treatment approach, study shows

Opening all blocked arteries with stents in patients with a heart attack, known as complete revascularization, reduces the risk of death from cardiovascular causes, death from any cause and future heart attacks compared with ...

Study challenges advice to avoid coffee for those with atrial fibrillation

Drinking coffee can protect against atrial fibrillation (A-Fib), a common heart rhythm disorder that causes rapid, irregular heartbeat and can lead to stroke and heart failure.

PCSK9 inhibitor lowers risk of first heart attack and stroke in high-risk adults

Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients' treatment significantly reduced the risk of major adverse cardiovascular events ...

Weight loss drugs don't increase risk of pancreatitis, adverse cardiac events in patients with high triglycerides: Study

In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis or adverse cardiac events.

More prenatal visits linked to right level of care for infants born with heart defects

In cases of mild congenital heart defects, more prenatal visits are associated with a greater likelihood of appropriate delivery at a community hospital, according to a study published in JAMA Network Open. Results suggest ...

Any hypertension during pregnancy significantly increases postpartum cardiovascular risk, study finds

A new study from researchers at Intermountain Health reveals that hypertensive disorders of pregnancy (HDP) significantly increase the risk of cardiovascular complications—including heart attack, stroke, heart failure, ...

Targeted vitamin D3 supplementation cuts risk of second heart attack in half, study finds

A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new study from heart researchers at Intermountain Health in Salt ...

Coronary artery calcium may be a predictor for all-cause mortality, including non-cardiac conditions

In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients who have no evidence of calcium in their coronary arteries are not only significantly less likely ...

Recommended News For You

Cancer Patients' Depression May Be Helped by Psilocybin.

AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC

Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD

Are ultramarathon runners really at increased risk of bowel cancer?

Integrative palliative care is critical to improving mental health among pancreatic cancer patients

'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning

Dual-action mRNA vaccine takes aim at aggressive skin cancer

Recommended Articles For You

Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights 

Precision Medicine and Genomics: Harnessing Longitudinal Data Modeling to Decode Cancer Progression 

Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained 

Cancer Vaccines In India: The Latest Hope In The Fight Against Disease 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

2.

Use of social media during pregnancy may increase depression.

3.

Asymptomatic or Minimally Symptomatic Myelofibrosis

4.

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

5.

The Cherenkov color image shows the possibility of improving the quality of radiation therapy.

1.

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies

2.

How Bispecific Antibodies are Redefining Medical Oncology in the US - A 2025 Review

3.

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches

4.

A Revolutionary Guide to Calculating Absolute Neutrophil Counts

5.

Uncovering the Hidden Symptoms of Parathyroid Cancer in Women

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Efficient Management of First line ALK-rearranged NSCLC

2.

Understanding the causes of anemia in adults beyond nutritional deficiencies

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

4.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

5.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot